| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 04/29/2004 | US20040082651 Epothilone synthesis building blocks III and IV: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones B, D and epothilone derivatives |
| 04/29/2004 | US20040082647 Anticholesterol agents; controlling bile acid transfer into intestines |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082601 Anti-inflammatory compounds |
| 04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2501265A1 Inhibitors of histone deacetylase |
| 04/28/2004 | EP1412320A1 Linked cyclitols and their polysulfated derivatives |
| 04/28/2004 | EP1412317A1 Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities |
| 04/28/2004 | EP1229031B1 Process for the preparation of 3,4-methylenedioxy-mandelic acid |
| 04/28/2004 | EP1051394B1 Potassium channel inhibitors |
| 04/28/2004 | EP0403618B2 Methyl esters of aldimino- or ketimino-oxy-ortho-tolylacrylic acid, manufacturing process and fungicides containing them |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1491937A 农药 Pesticide |
| 04/28/2004 | CN1147459C Galcium receptor-active compound |
| 04/28/2004 | CN1147294C Pentafluorobenzenesulfonamides and analogs |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/22/2004 | WO2004033443A1 Halogen substituted hexahydroxy biphenyl derivatives, their preparation and their uses as medicament |
| 04/22/2004 | WO2004033415A1 Nitroaniline-based alkylating agents and their use as prodrugs |
| 04/22/2004 | WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases |
| 04/22/2004 | WO2003041728A9 Novel phenyl-propargylether derivatives |
| 04/22/2004 | US20040077867 Amine compounds, their production and use |
| 04/22/2004 | US20040077726 Antiproliferative and anticarcinogenic agents; psoriasis |
| 04/22/2004 | US20040077553 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 04/21/2004 | EP1409440A1 A method to inhibit ethylene responses in plants |
| 04/21/2004 | EP1208077B1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1146552C Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 04/20/2004 | US6723749 Treating bacterial infections |
| 04/20/2004 | US6723743 Treating patient suffering from rheumatoid arthritis, psoriasis, bronchial asthma, alzheimer's disease, myocardial infarction or atherosclerosis |
| 04/20/2004 | US6723711 Vascular cell adhesion molecules and fibronectins; asthma, multiple sclerosis, arthritis, inflammatory bowel disease, contact hypersensitivity, cardiac allograft rejection and diabetes treatment |
| 04/15/2004 | WO2004031167A1 Alkyl glycidol carbonates used as co-surfactants |
| 04/15/2004 | WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 04/15/2004 | WO2004031111A1 Reaction products of 2-propylheptanol with 1-halogen-2,3-epoxypropanes and 1-hydroxy-2,3-epoxypropane |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 04/15/2004 | US20040073046 Crosslinking polyurethanes |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 04/15/2004 | US20040072690 Such as (R)-3-(4-(2-(3-(2,4-difluorophenyl)-1-heptylureido) ethoxy)phenyl)-2-ethoxypropionic acid; for prophylaxis/therapy of diabetes/hyperlipidemia |
| 04/15/2004 | DE10246140A1 Umsetzungsprodukte von 2-Propylheptanol mit1-Halogen-2,3-epoxypropanen und 1-Hydroxy-2,3-epoxypropan Reaction products of 2-propylheptanol with1-halo-2,3-epoxypropanen and 1-hydroxy-2,3-epoxypropane |
| 04/15/2004 | DE10246139A1 Alkylglycidolcarbonate als Co-Tenside Alkylglycidol as cosurfactants |
| 04/15/2004 | CA2500793A1 Reaction products of 2-propylheptanol with 1-halo-2,3-epoxypropanes and 1-hydroxy-2,3-epoxypropane |
| 04/15/2004 | CA2500780A1 Alkyl glycidol carbonates used as co-surfactants |
| 04/14/2004 | EP1406886A1 Process for the recovery of a polyol from an aqueous solution |
| 04/14/2004 | EP1406861A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1305270B1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 04/14/2004 | EP1286954B1 7-substituted fused ring tetracycline compounds |
| 04/14/2004 | EP1100772B1 Open chain alkoxyamine compounds and their use as polymerization regulators |
| 04/14/2004 | EP0724561B1 Calcium receptor-active arylalkyl amines |
| 04/14/2004 | CN1146065C Non-aqueous electrolyte for electrochemical systems and lithium accumulator comprising same |
| 04/13/2004 | US6720439 Synthesis of ruthenium-hydride complexes and preparation procedures of chiral alcohols and ketones |
| 04/13/2004 | US6720425 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/13/2004 | US6720169 By converting the corresponding acetal-protected aldehyde into the corresponding aminonitrile, converting the aminonitrile into the corresponding amino acid amide, and performing enzymatic, enantioselective hydrolysis |
| 04/08/2004 | WO2004028445A2 Processes for preparing 1,3-dioxolane nucleosides |
| 04/08/2004 | WO2004009564A3 Co-surfactants based on aldehydes |
| 04/08/2004 | US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/07/2004 | EP1404665A1 Antimicrobial and radioprotective compounds |
| 04/07/2004 | EP1404664A1 Aminediols for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | EP1127060B1 Hydroboronation process |
| 04/06/2004 | CA2121060C Preparation of lignan analogues |
| 04/01/2004 | WO2004026850A1 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiaoles from cyclohexanes and cyclohexanones as intermediates |
| 04/01/2004 | WO2004026816A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2003088927A3 Novel curcumin analogues and uses thereof |
| 04/01/2004 | WO2003059874A3 Aromatic thioether liver x-receptor modulators |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063781 Compounds active at the glucocorticoid receptor II |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063669 Alpha-phenyl-beta-ketosulfone |
| 04/01/2004 | CA2499213A1 Aromatic liver x-receptor modulators |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 03/31/2004 | EP1402890A1 Sulfonamide derivatives |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401824A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 03/31/2004 | EP1401798A1 Integrated process for preparing dialkyl carbonates with a circulating catalyst |
| 03/31/2004 | EP1401575A1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/31/2004 | CN1486313A Compounds for use in the treatment of skin conditions |
| 03/30/2004 | US6713640 Process for the recovery of a polyol from an aqueous solution |
| 03/30/2004 | US6713580 Quaternary amino acids on solid supports |
| 03/25/2004 | WO2004024681A2 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines |
| 03/25/2004 | WO2003069350A3 Small molecule modulators of apoptosis |
| 03/25/2004 | WO2003041728A8 Novel phenyl-propargylether derivatives |
| 03/25/2004 | WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 03/25/2004 | US20040059149 Method for the synthesis of compounds of formula 1 and derivatives thereof |